During the past decade, Davis Heart and Lung Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Davis Heart and Lung Research Institute" #1 sponsor was "Ohio State University" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Duke University" with 2 trials sponsored, "Ohio Willow Wood" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Davis Heart and Lung Research Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Natreon, Inc." with 2 trials as a collaborator, "Ohio State University" with 2 trials as a collaborator and "American Lung Association Asthma Clinical Research Centers" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Davis Heart and Lung Research Institute" are "Asthma" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "Heart Failure" (2 trials), "Lower Limb Amputation" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Davis Heart and Lung Research Institute" in a lesser frequency.

Most popular intervention types in "Davis Heart and Lung Research Institute" are "Drug" (11 trials), "Other" (4 trials), "Device" (3 trials), "Dietary Supplement" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials), "Blood Draw" (1 trials) and "Capros" (1 trials). Other intervention names were less common.

The vast majority of trials in "Davis Heart and Lung Research Institute" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Davis Heart and Lung Research Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Davis Heart and Lung Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Davis Heart and Lung Research Institute, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".